Mount Lucas Management LP Purchases 51,000 Shares of Alpha Teknova, Inc. (NASDAQ:TKNO)

Mount Lucas Management LP increased its stake in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) by 566.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 60,000 shares of the company's stock after purchasing an additional 51,000 shares during the quarter. Mount Lucas Management LP owned approximately 0.11% of Alpha Teknova worth $311,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of TKNO. Larson Financial Group LLC bought a new stake in shares of Alpha Teknova in the 1st quarter worth approximately $30,000. JPMorgan Chase & Co. raised its holdings in shares of Alpha Teknova by 622.5% in the 4th quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after purchasing an additional 3,791 shares during the period. Stratos Wealth Advisors LLC bought a new stake in shares of Alpha Teknova in the 1st quarter worth approximately $59,000. Two Sigma Investments LP raised its holdings in shares of Alpha Teknova by 46.2% in the 4th quarter. Two Sigma Investments LP now owns 15,148 shares of the company's stock worth $126,000 after purchasing an additional 4,789 shares during the period. Finally, NewEdge Advisors LLC raised its holdings in shares of Alpha Teknova by 14.3% in the 4th quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock worth $131,000 after purchasing an additional 1,953 shares during the period. Institutional investors own 13.81% of the company's stock.

Alpha Teknova Stock Performance

Shares of NASDAQ:TKNO traded up $0.01 during trading on Friday, hitting $5.18. 126,957 shares of the company were exchanged, compared to its average volume of 384,496. The company has a market cap of $276.82 million, a PE ratio of -10.79 and a beta of 0.33. The stock has a 50 day moving average of $5.39 and a 200 day moving average of $6.31. Alpha Teknova, Inc. has a 52-week low of $3.26 and a 52-week high of $10.37. The company has a debt-to-equity ratio of 0.17, a current ratio of 5.64 and a quick ratio of 4.71.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.02. Alpha Teknova had a negative return on equity of 28.48% and a negative net margin of 60.90%. The firm had revenue of $9.60 million for the quarter, compared to the consensus estimate of $9.41 million. As a group, equities research analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Insider Activity

In related news, Director Martha J. Demski sold 8,000 shares of the stock in a transaction on Friday, June 27th. The stock was sold at an average price of $5.06, for a total value of $40,480.00. Following the sale, the director owned 12,000 shares in the company, valued at approximately $60,720. This trade represents a 40.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 12.50% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Stephens raised shares of Alpha Teknova to a "strong-buy" rating and set a $8.00 price target on the stock in a report on Tuesday, July 22nd.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.